CAREDX INC.

In News

CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response - Yahoo Finance

Yahoo Finance - Jan 07, 2026

CareDx, 10x Genomics Establish Multiomics Research Initiative - Contract Pharma

Contract Pharma - Jan 07, 2026

Assessing CareDx (CDNA) Valuation After ImmuneScape Multiomics Collaboration With 10x Genomics - Sahm

Sahm - Jan 07, 2026

CareDx, Inc. and 10x Genomics to Launch ImmuneScape - A Multiomics Research Platform to Decode Transplant Rejection and Drug Response - MarketScreener

MarketScreener - Jan 07, 2026

CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Business Wire - Dec 26, 2025

CareDx and 10x Genomics partner on transplant rejection research By Investing.com - Investing.com Nigeria

Investing.com Nigeria - Jan 08, 2026

Why CareDx Inc stock is popular among millennials - Gap Down & Verified Chart Pattern Signals - ulpravda.ru

ulpravda.ru - Jan 10, 2026

CareDx, Inc. (NASDAQ:CDNA) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat

MarketBeat - Dec 22, 2025

CareDX Has Reached An Inflection Point, But Regulatory Risks Remain (Upgrade) (CDNA) - Seeking Alpha

Seeking Alpha - Dec 22, 2025

CareDx Provides Notice of Proposed Derivative Settlement - Yahoo Finance

Yahoo Finance - Dec 18, 2025

CareDx, 10x Genomics Launch Platform to Study Transplant Rejection and Drug Response - MarketScreener

MarketScreener - Jan 07, 2026

CareDx Announces Appointment of Nathan Smith as Chief Financial Officer - Business Wire

Business Wire - Aug 06, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment